Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 7 results.
User Information
Export Records
  1. 1.   Engineering CD276/B7-H3-targeted antibody-drug conjugates with enhanced cancer-eradicating capability
  2. Feng,Yang; Lee,Jaewon; Yang,Liping; Hilton,Mary; Morris,Karen; Seaman,Steven; Edupuganti,Shivaji; Hsu,Kuo-Sheng; Dower, Christopher; Yu,Guojun; So,Daeho; Bajgain,Pradip; Zhu, Zhongyu; Dimitrov, Dimiter S; Patel,Nimit; Robinson,Christina; Difilippantonio,Simone; Dyba,Marzena; Corbel,Amanda; Basuli, Falguni; Swenson, Rolf E; Kalen,Joseph; Suthe, Sreedhar Reddy; Hussain, Myer; Italia, James S; Souders, Colby A; Gao, Ling; Schnermann,Martin; St Croix,Brad
  3. Cell Reports. 2023, Nov 28; 42(12): 113503.
  1. 2.   Heterodimeric IL-15 (hetIL-15) reduces circulating tumor cells and metastasis formation improving chemotherapy and surgery in 4T1 mouse model of TNBC
  2. Stravokefalou, Vasiliki; Stellas, Dimitris; Karaliota,Sevasti; Nagy,Bethany; Valentin, Antonio; Bergamaschi, Cristina; Dimas, Konstantinos; Pavlakis,George
  3. Frontiers in Immunology. 2022, Jan 13; 13: 1014802.
  1. 3.   Eribulin Regresses a Cisplatinum-resistant Rare-type Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft Mouse Model
  2. Yamamoto, Jun; Murata, Takuya; Sugisawa, Norihiko; Higuchi, Takashi; Tashiro, Yoshihiko; Nishino, Hiroto; Inubushi, Sachiko; Sun, Y U; Lim, Hyein; Miyake, Kentaro; Shimoya, Koichiro; Nomura, Tsunehisa; Kurebayashi, Junichi; Tanino, Hirokazu; Hozumi, Chihiro; Bouvet, Michael; Singh,Shree Ram; Endo, Itaru; Hoffman, Robert M
  3. Anticancer research. 2020, May; 40(5): 2475-2479.
  1. 4.   A Single Low Dose of Eribulin Regressed a Highly Aggressive Triple-negative Breast Cancer in a Patient-derived Orthotopic Xenograft Model
  2. Lim, Hye In; Yamamoto, Jun; Inubushi, Sachiko; Nishino, Hiroto; Tashiro, Yoshihiko; Sugisawa, Norihiko; Han, Quinhong; Sun, Y U; Choi, Hee Jun; Nam, Seok Jin; Kim, Moon Bo; Lee, Ji Sun; Hozumi, Chihiro; Bouvet, Michael; Singh,Shree Ram; Hoffman, Robert M
  3. Anticancer research. 2020, May; 40(5): 2481-2485.
  1. 5.   A Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft (PDOX) Mouse Model Is Sensitive to Bevacizumab and Vinorelbine, Regressed by Eribulin and Resistant to Olaparib
  2. Yamamoto, Jun; Murata, Takuya; Tashiro, Yoshihiko; Higuchi, Takashi; Sugisawa, Norihiko; Nishino, Hiroto; Inubushi, Sachiko; Sun, Y U; Lim, Hyein; Miyake, Kentaro; Hongo, Atsushi; Nomura, Tsunehisa; Saitoh, Wataru; Moriya, Takuya; Tanino, Hirokazu; Hozumi, Chihiro; Bouvet, Michael; Singh,Shree Ram; Endo, Itaru; Hoffman, Robert M
  3. Anticancer research. 2020, May; 40(5): 2509-2514.
  1. 6.   Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
  2. Cheng, Robert Y S; Patel,Nimit; Back, Timothy; Basudhar,Debashree; Somasundaram,Veena; Kalen,Joseph; Wink,David; Ridnour,Lisa
  3. Journal of visualized experiments : JoVE. 2020, Mar 20; (157):
  1. 7.   Adaptation of Laser Microdissection Technique to Nanostring RNA Analysis in the Study of a Spontaneous Metastatic Mammary Carcinoma Mouse Model
  2. Castro, Nadia P; Golubeva, Yelena
  3. Methods in molecular biology (Clifton, N.J.). 2018 1723: 119-137.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel